| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.1M | -47.5% |
| Cost of Revenue | $2K | -97.0% |
| Gross Profit | $1.1M | -45.9% |
| R&D Expense | $9.2M | -6.1% |
| SG&A Expense | $19.2M | -12.6% |
| Operating Income | -$27.3M | +8.2% |
| Pre-tax Income | -$30.5M | +12.8% |
| Income Tax | $0 | — |
| Net Income | -$30.5M | +12.8% |
| EPS (Basic) | -$49.10 | -111.7% |
| EPS (Diluted) | -$49.10 | -111.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.8M | +714.6% |
| Accounts Receivable | $0 | -100.0% |
| Current Assets | $22.3M | +392.3% |
| Total Assets | $40.3M | +305.1% |
| Current Liabilities | $16.1M | +7.1% |
| Total Liabilities | $23.2M | +30.5% |
| Stockholders' Equity | $17.1M | +319.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$23.3M | -40.1% |
| Capital Expenditures | $12K | — |
| Investing Cash Flow | -$12K | -112.8% |
| Financing Cash Flow | $34.6M | +121.7% |
| Free Cash Flow | -$23.3M | -40.2% |